Pharma & Biotech

Shares of Abeona Therapeutics advanced 1.46% to $6.95 in the previous session as investor focus sharpened on the company's upcoming...

A notable institutional investor has established a new position in Viking Therapeutics, providing fresh momentum for the biopharmaceutical stock. This...

The acquisition of Inozyme Pharma Inc by BioMarin Pharmaceutical was formally completed in July, marking a significant consolidation in the...

Despite completing its transition to private ownership in October 2024, PetIQ finds itself navigating significant legal challenges. The animal health...

In a significant consolidation within the biotechnology sector, Swiss pharmaceutical giant Roche has finalized its acquisition of Poseida Therapeutics, effectively...

A landmark court decision has removed the most significant legal threat facing the rapidly expanding market for affordable weight-loss medications....

The story of Absci Corporation presents investors with a puzzling dichotomy. On one hand, the biotechnology firm faces stark financial...

Shares of Aclaris Therapeutics experienced a notable advance today, climbing more than 3.5 percent. This upward movement comes directly on...

Biotechnology firm Ocugen approaches a pivotal moment that could define its trajectory for the coming year. The company's presentation at...

Shares of Voyager Therapeutics have registered notable gains after a series of presentations at investor conferences. The biotechnology company's stock...